| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +18% |
| 3Y CAGR | -2% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +27% |
| 3Y CAGR | -31% |
| Fund name | AUM% |
|---|---|
| 0.53 |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,364.60 +28.20 (1.21%) | 17,770.39 | 26.21 | 5.27 | ||
PfizerPFIZER | ₹3,821.60 +182.90 (5.03%) | 16,642.57 | 22.64 | 3.96 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,345.00 +53.50 (0.85%) | 15,708.13 | 92.61 | 18 | ||
Natco PharmaNATCOPHARM | ₹781.60 -4.15 (0.53%) | 15,419.78 | 13.47 | 1.47 |